跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APROXXAMLO 300 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
APROXXAMLO 300 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
APROXXAMLO 300 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Sanofi Aventis S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 25, 2020
Approval ID
5ca7c5897567ffc8
Company
Sanofi Aventis S.A.
Type
Standard
Approval Details
Approval Id
5ca7c5897567ffc8
Drug Cima Aemps Name
APROXXAMLO 300 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
85201
Holder Company Name
Sanofi Aventis S.A.
Marketing Company Name
Sanofi Aventis S.A.
Authorization Date
2020-06-25
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
300 mg/5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sanofi Aventis S.A.
Active Ingredients
IRBESARTAN
300 mg
AMLODIPINO BESILATO
7 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 25, 2020
Approval ID
5ca7c5897567ffc8
Type
Standard
Back to CIMA-AEMPS Approvals